Can Fite Stock Target Price and Analyst Consensus

CANF Stock  USD 1.58  0.06  3.95%   
The current analyst and expert consensus on Can Fite is Strong Buy, with only one strong buy opinion. The current projected Can Fite target price consensus is 17.33 with 2 analyst opinions. Check out Macroaxis Advice on Can Fite to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
The most common way Can Fite Biopharma analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Can Fite executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Can Fite. We encourage you to use your own analysis of Can Fite Biopharma to validate this buy or sell advice. Can Fite buy-or-sell recommendation module provides average expert sentiment on the projected Can Fite Biopharma target price to derive its highest and lowest estimates based on projected price volatility of 5.011.
Lowest Forecast
15.77
Highest Forecast
19.24
Target Price
17.33
The Can Fite's current Gross Profit is estimated to increase to about 1.1 M, while Pretax Profit Margin is projected to decrease to (10.79). At this time, Can Fite's Property Plant And Equipment Net is most likely to increase significantly in the upcoming years. The Can Fite's current Accounts Payable is estimated to increase to about 833 K, while Other Current Liabilities is projected to decrease to roughly 891.4 K.
  
It's important to approach Can Fite's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Can Fite price targets

Can Fite's stock target price is an estimate of its future price, usually made by analysts. Using Can Fite's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Can Fite's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Can Fite's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Can Fite Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Can Fite is a key component of Can Fite valuation and have some predictive power on the future returns of a Can Fite.
Hype
Prediction
LowEstimatedHigh
0.081.626.63
Details
Intrinsic
Valuation
LowRealHigh
0.505.5110.52
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested over 40 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 50 shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 50 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
FinTech Idea
FinTech
Invested over 40 shares
Social Domain Idea
Social Domain
Invested few shares
Impulse Idea
Impulse
Invested few shares
Investing Idea
Investing
Invested few shares
Electronic Equipment Idea
Electronic Equipment
Invested few shares
When determining whether Can Fite Biopharma is a strong investment it is important to analyze Can Fite's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Can Fite's future performance. For an informed investment choice regarding Can Stock, refer to the following important reports:
Check out Macroaxis Advice on Can Fite to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.